A practical clinical approach to liver fibrosis

Area of Science:

• Hepatology
• Internal Medicine
• Diagnostic Medicine

Background:

• Liver fibrosis, characterized by extracellular matrix accumulation, is a critical determinant of morbidity and mortality in chronic liver disease (CLD).
• The increasing prevalence of non-alcoholic fatty liver disease (NAFLD), diabetes mellitus, and obesity contributes to a rising burden of CLD.
• Accurate staging of liver fibrosis is essential for prognosis and guiding clinical management decisions.

Purpose of the Study:

• To evaluate the utility of noninvasive composite scores in staging liver fibrosis among patients with CLD.
• To determine the role of these scores in differentiating patients who can be managed in primary care versus those requiring specialist referral.

Main Methods:

• Utilized noninvasive composite scoring systems to assess the stage of liver fibrosis in patients with CLD.
• Correlated composite score results with clinical management pathways, including primary care follow-up and specialist referral.

Main Results:

• Noninvasive composite scores effectively distinguish between significant and advanced liver fibrosis.
• Patients with low composite scores can be safely managed with periodic reassessment in primary care.
• Higher composite scores indicate advanced fibrosis, necessitating referral to a specialist for further evaluation and management.

Conclusions:

• Easy-to-use fibrosis assessment composite scores are valuable tools for identifying patients with minimal or advanced liver fibrosis.
• These scores should be integrated into clinical decision-making processes for patients with CLD.
• Referral criteria include cirrhosis, high composite scores, and specific indicators of liver injury in chronic hepatitis B or cases with uncertain etiology.